Trials / Completed
CompletedNCT04036487
Effects of General Anesthesia on Quality of Recovery After Transaxillary Endoscopic Breast Augmentation
Chimay Plastic Surgery Clinic, Taipei
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Chih-Cheng Hung · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Among aesthetic or cosmetic surgeries, breast augmentation was the most frequently performed and the endoscopic transaxillary approach has become the preferred incision for Asian women. As breast augmentation must be performed under general anesthesia accompanied by its effects and potential complications, types of general anesthesia may affect the quality of recovery. Currently, the two most common techniques of general anesthesia are inhalation anesthesia (IH) and total intravenous anesthesia (TIVA). The effects of these types of general anesthesia on the quality of recovery have been investigated for numerous surgical procedures. However, no prior studies have analyzed different types of anesthesia used for performing transaxillary endoscopic breast augmentation. This prospective, parallel, randomized controlled study will evaluate the effects of inhalation anesthesia vs. total intravenous anesthesia on the quality of recovery in patients undergoing transaxillary endoscopic breast augmentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desflurane | Anesthesia is maintained by desflurane in an oxygen air mixture of 60/40%. If inadequate depth of anesthesia is observed, the end-expiratory concentration of desflurane would be increased. |
| DRUG | Propofol | Anesthesia is maintained by propofol 100-200 μg/kg/min. If inadequate depth of anesthesia is observed, the rate of propofol infusion would be increased. |
Timeline
- Start date
- 2017-07-28
- Primary completion
- 2018-05-30
- Completion
- 2018-05-31
- First posted
- 2019-07-29
- Last updated
- 2019-08-12
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04036487. Inclusion in this directory is not an endorsement.